BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31884500)

  • 1. Fibrosarcomatous Change in a Dermatofibrosarcoma Protuberans: Significance and Implications in the Differential Diagnosis of the Coexpression of S100 Protein and CD34 in Both Components.
    Sabater-Marco V
    Am J Dermatopathol; 2020 Jan; 42(1):71-74. PubMed ID: 31884500
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrosarcomatous dermatofibrosarcoma protuberans with giant rosettes.
    Zamecnik M
    Am J Dermatopathol; 2001 Feb; 23(1):41-5. PubMed ID: 11176051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatofibrosarcoma Protuberans Presenting as a Large Atrophic Plaque on the Chest.
    Saigusa R; Miyagawa T; Toyama S; Omatsu J; Miyagaki T; Masui Y; Yamada D; Sato S
    Acta Derm Venereol; 2018 Jan; 98(1):155-156. PubMed ID: 28929166
    [No Abstract]   [Full Text] [Related]  

  • 5. A firm red-brown plaque on the arm. Dermatofibrosarcoma protuberans(DFSP), pigmented variant (Bednar tumor.
    Quigley EA; Marghoob AA; Busam KJ; Chen CS
    Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451510
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant.
    Wu JK; Malik MM; Egan CA
    Australas J Dermatol; 2004 Aug; 45(3):175-7. PubMed ID: 15250897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-headed nodules on the abdomen. Myxoid dermatofibrosarcoma protuberans (DFSP).
    Kunisada M; Nagai H; Shimizu H; Yogianti F; Nishiyama S; Nishigori C
    Arch Dermatol; 2011 Jul; 147(7):857-62. PubMed ID: 21768490
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
    Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
    Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent dermatofibrosarcoma protuberans with myxoid and fibrosarcomatous changes paralleled by loss of CD34 expression.
    Sato N; Kimura K; Tomita Y
    J Dermatol; 1995 Sep; 22(9):665-72. PubMed ID: 8537553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
    Garcia C; Viehman G; Hitchcock M; Clark RE
    Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant dermatofibrosarcoma protuberans of the face and scalp: a case report.
    Eguzo K; Camazine B; Milner D
    Int J Dermatol; 2014 Jun; 53(6):767-72. PubMed ID: 22913468
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.
    Mentzel T; Beham A; Katenkamp D; Dei Tos AP; Fletcher CD
    Am J Surg Pathol; 1998 May; 22(5):576-87. PubMed ID: 9591728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pigmented dermatofibrosarcoma protuberance: a clinicopathologic analysis of 7 cases].
    Zhang J; Zhang RS; Wei X; Shi QL; Zhou XJ; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):810-4. PubMed ID: 24507098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases.
    Llatjós R; Fernández-Figueras MT; Díaz-Cascajo C; Ribera M; Ariza A
    Histopathology; 2000 Nov; 37(5):452-5. PubMed ID: 11119127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Pigmented Fibrosarcomatous Dermatofibrosarcoma Protuberans: Answer.
    Cull D; Bowers N; Majerowski JM; Sangueza OP; Huang WW
    Am J Dermatopathol; 2022 Jan; 44(1):75-76. PubMed ID: 34889817
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bednar tumor (pigmented dermatofibrosarcoma protuberans) occurring in a site of prior immunization: immunochemical findings and therapy.
    Elgart GW; Hanly A; Busso M; Spencer JM
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):315-7. PubMed ID: 10025857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatofibrosarcoma protuberans with onset in early childhood: a case report.
    Navarro M; Requena C; Febrer I; Marin S; Aliaga A
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):154-5. PubMed ID: 12046821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibrosarcoma Protuberans of Distal Extremities and Acral Sites: A Clinicopathologic Analysis of 27 Cases.
    Shah KK; McHugh JB; Folpe AL; Patel RM
    Am J Surg Pathol; 2018 Mar; 42(3):413-419. PubMed ID: 29240584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.